The official journal of ARHP, Contraception: An International Reproductive Health Journal, is consistently ranked in the top tier of all journals in obstetrics and gynecology. Contraception is internationally recognized and peer-reviewed. In addition to groundbreaking research, the journal features a monthly editorial highlighting news and developments in reproductive health. Contraception editorials and abstracts are available at no cost, but access to full articles requires a subscription.
May 2012
Emergency contraception: global challenges, new opportunities
Elizabeth Westley, Eleanor Bimla Schwarz
pages 429-431
Emergency contraception (EC) is unique among modern contraceptive methods in its capacity to prevent pregnancy after sex. Perhaps for this reason, from the days of its earliest introduction, EC has engendered extraordinary anxiety and opposition in multiple settings around the world. This was most recently demonstrated by the US Secretary for Health and Human Services Kathleen Sibelius' unprecedented interference with US drug regulatory processes when she overruled the US Food and Drug Administration's approval of full over-the-counter status for all ages of a brand of levonorgestrel EC. Subsequently, President Obama added that he agreed with the decision, commenting that 11-year-olds should not be able to access EC as easily as “bubblegum and batteries”. read more >
Avoiding controversy in international provision of subdermal contraceptive implants
David Hubacher, Laneta Dorflinger
pages 432-433
International agencies work with host country governments to estimate contraceptive needs and to procure commodities at affordable public-sector prices. Depending on the agency and the registration status of the commodity in the given country, three subdermal contraceptive implants are options for purchase: Jadelle® is a two-rod levonorgestrel implant approved for 5 years of continuous use (Bayer HealthCare, Berlin, Germany), Implanon® (Merck & Co., Inc., Whitehouse Station, NJ, USA) is a one-rod etonogestrel implant (approved for 3 years) and Sino-implant (II) (Shanghai Dahua Pharmaceutical Co., Ltd., China) is another two-rod levonorgestrel implant (approved for 4 years). read more >
Contraception highlights from May 2012
Past Issues
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
A Fast Track Solution for Reducing Unintended Pregnancies in the US: Increase Federal Support for Life-Long Provider Education and Training in Reproductive Health
August 2009
Advancing Scope of Practice for Advanced Practice Clinicians: More Than a Matter of Access
July 2009
Emergency Contraception: Have We Come Full Circle?
May 2009
Beyond Education and Training: Making Change Stick
April 2009
A Call to Incorporate a Reproductive Justice Agenda into Reproductive Health Clinical Practice and Policy
March 2009 (two editorials)
February 2009
Science Prevails: Abortion and Mental Health
January 2009
Beyond A Prescription: Strategies for Improving Contraceptive Care
December 2008
An Evolving Landscape: Reproductive Genetics, New Technologies and Health Care Over the Next Decade
November 2008 (two editorials)
September 2008
The Potential of Long-acting Reversible Contraception to Decrease Unintended Pregnancy
August 2008
You Say "Regret"; and I Say "Relief": A Need to Break the Polemic About Abortion
July 2008
The Lost Years: The Challenge of Delivering Reproductive Health Care to Young Adults
June 2008
Freedom Closes the Gap
March 2008
The Continuum of Care: A Case for Pharmacists as Key Members of the Reproductive Health Care Team
January 2008
Reducing Unintended Pregnancy in the United States
December 2007
Family Planning and Access to Safe and Legal Abortion Are Vital to Safeguard the Environment
November 2007
From American Idol to Plan B: A Call for a Shift in Priorities
October 2007
The Clinical Implications of Screening for Violence Against Women
September 2007
Maintaining Access to Safe Abortion in the United States: A Post-Gonzales Primer and Guide to Action
August 2007
Protecting Confidentiality to Safeguard Adolescents' Health: Finding Common Ground
July 2007
Providers, Parents and Communication: The Keys to Healthy Teens and Reducing Teen Pregnancy Rates
June 2007
Why We Need to Truly Understand the Medical Literature
May 2007
Cultural Competence: An International Perspective
March 2007
Leadership and Diversity: A Call For New Directions in Reproductive Health Education and Practice
February 2007
Securing the Future: A Case for Improving Clinical Education in Reproductive Health
January 2007
Faith Matters: Communicating Sexual and Reproductive Health Values
December 2006
Ten Priorities for Women's Health (PDF)
November 2006
Why I Read the Contraception Editorials: Another Perspective from a Nontraditional Association of Reproductive Health Professionals Member (PDF)
October 2006
HPV Vaccines: Now That They're Here, How Do We Maximize Their Benefit? (PDF)
September 2006
Adding Value to Reproductive Health Research: Communicating About the Moral Dimensions of Science (PDF)
August 2006
Mechanism of Action of Emergency Contraception Pills (PDF)
July 2006
Morality and the Abortion Provider (PDF)
June 2006
The Society of Family Planning (PDF)
May 2006
Reproductive Health Risks in Perspective (PDF)
February 2006 (two editorials)
January 2006
Can We Improve Contractive Use? (PDF)
December 2005
Is Family Planning a Subspecialty of Obstetrics and Gynecology? (PDF)
November 2005
Improving Contraceptive Technology: Is It A Zero-Sum Game? (PDF)
October 2005
Millennium Development Goals: Slow Movement Threatens Women's Health in Developing Countries (PDF)
September 2005
Depo-Provera's Black Box: Time to Reconsider? (PDF)
August 2005
How Do We Ensure "High Quality" Clinical Research? (PDF)
July 2005
Family Planning for Obese Women: Challenges and Opportunities (PDF)
June 2005
Healthy Sexuality (PDF)
May 2005
Contraceptive Equity and Access in the United States: A 2005 Update (PDF)
April 2005
Religion and Medicine (PDF)
March 2005
Risks of Mifepristone Abortion in Context (PDF)
February 2005
The Expanding Role of Genetics in Contraception and Women's Health (PDF)
December 2004
In the New Year, a New Beginning to End HIV/AIDS (PDF)
November 2004
Universal Insurance Coverage for Contraceptives: A Public Health Imperative (PDF)
October 2004
Ten Priorities for Women's Health (PDF)
September 2004
A Prescription for Real Security (PDF)
August 2004
The 2005 United States Budget: Wasteful Expenditures, Foregone Opportunities (PDF)
July 2004
Cairo Goals for Reproductive Health: Where Do We Stand at 10 Years? (PDF)
June 2004
The Federal Abortion Ban: A Clinical and Moral Dilemma, and International Policy Setback (PDF)
May 2004
Faulty Assumptions, Harmful Consequences: Coming to Terms with Adolescent Sexuality (PDF)
April 2004
Family Planning Care: More Than Contraception (PDF)
March 2004
Presenting Health Risks Honestly: Mifepristone, A Case in Point (PDF)
February 2004
Making Research Matter (PDF)
January 2004
A New Year's Resolution for Reproductive Health Care (PDF)
November 2003
Keeping Abortion Legal: A Look Beyond Roe v. Wade (PDF)
October 2003
Why We Should "Just Say No" To Exclusive Abstinence-Only Funding (PDF)
September 2003
The War on Words: Sensible Compromise or Slow Suicide? (PDF)
August 2003
Reproductive Health Care: An Essential Foundation for Prosperity and Peace (PDF)
July 2003
Title X: A Sure Fire Investment with at Least a 300 Percent Return (PDF)
May 2003
Supporting Emergency Contraception Over-the-counter (PDF)
April 2003
Preserving Core Values in Science (PDF)
